pediagenosis: Digestive
Article Update
Loading...
Showing posts with label Digestive. Show all posts
Showing posts with label Digestive. Show all posts

Saturday, June 13, 2026

Esophagoscopy and Endoscopic Ultrasound (EUS): Advanced Technology for Early Detection of Esophageal Cancer

Esophagoscopy and Endoscopic Ultrasound (EUS): Advanced Technology for Early Detection of Esophageal Cancer


Esophagoscopy and Endoscopic Ultrasound


Esophagoscopy and Endoscopic Ultrasound
The ability of being able to introduce a flexible instrument with a charge­coupled device safely into the gastrointestinal tract has revolutionized the practice of gastroenterology. Endoscopic examination of the esophagus shows extensive detail of the mucosal lining, some imaging of abnormalities that lead to intramural or extramural indentation or compression of the lumen, respectively, and esophageal motility abnormalities as estimated by sphincter tone and esophageal diameter. Mucosal abnormalities seen are best characterized as inflammatory or neoplastic. Inflammatory lesions may vary in intensity from mild superficial erythema to frank ulceration with complete destruction of the mucosa. 

Saturday, May 2, 2026

Manifestations of Disease of Tongue

Manifestations of Disease of Tongue


Manifestations of Disease of Tongue

Manifestations of Disease of Tongue



As a consequence of the easy accessibility to clinical inspection, the tongue, in the course of medical history, has played a rather special role as a diagnostic indicator of systemic disease. The degree of moisture or dryness of the lingual mucosa may indicate disturbances of fluid balance. Changes in color and the appearance of edema, swelling, ulcers, and inflammation or atrophy of the lingual papillae may represent signs of endocrine, nutritional, hematologic, metabolic, or hepatic disorders, infectious diseases, or aberrant ingestions. On the other hand, it should be recognized that the tongue participates with the gingivae and the buccal mucosa in localized pathologic processes of the oral cavity, and that a number of conditions exist in which the surface or the parenchyma of the tongue itself is exclusively involved.
Benign Tumors of Oral Cavity

Benign Tumors of Oral Cavity


Benign Tumors of Oral Cavity


Benign Tumors of Oral Cavity


Tumors of the oral cavity are very diversified. Only a select few can be discussed here. A fibroma may be found on the gingiva, lips, palate, and buccal mucosa. It is hard or soft and pale or reddish, depending on the density of collagen and the abundance of vascular elements. The gingival fibroma (fibrous epulis) is usually derived from the periosteum. It is sessile or pedunculated, well defined, and slow growing.

Thursday, February 19, 2026

CARBOHYDRATE MALABSORPTION, INCLUDING LACTOSE MALABSORPTION

CARBOHYDRATE MALABSORPTION, INCLUDING LACTOSE MALABSORPTION

CARBOHYDRATE MALABSORPTION, INCLUDING LACTOSE MALABSORPTION


CARBOHYDRATE MALABSORPTION, INCLUDING LACTOSE MALABSORPTION


Carbohydrate malabsorption is a frequent clinical condition caused by fermentation of unabsorbed carbohydrates by colonic flora and giving rise to symptoms. Although lactose is the most commonly malabsorbed sugar, other carbohydrates, including oligosaccharides, disaccharides, and monosaccharides such as fructose, can cause symptoms related to malabsorption.

LYMPHANGIECTASIA AND ABETALIPOPROTEIN DEFICIENCY

LYMPHANGIECTASIA AND ABETALIPOPROTEIN DEFICIENCY

LYMPHANGIECTASIA AND ABETALIPOPROTEIN DEFICIENCY

LYMPHANGIECTASIA AND ABETALIPOPROTEIN DEFICIENCY


Intestinal Lymphangiectasia

Intestinal lymphangiectasia is an unusual disorder characterized by dilated lymphatic channels in the mucosa, submucosa, or subserosa of the small intestine, leading to protein-losing enteropathy. Waldman originally described an idiopathic form, primary intestinal lymphangiectasia; however, obstruction to the flow of lymph in certain cardiac diseases or hematologic malignant diseases and retroperitoneal lymph node enlargement due to chemotherapeutic, infectious, or toxic agents can secondarily lead to lymphangiectasias that present in the same manner as primary intestinal lymphangiectasia.

EOSINOPHILIC GASTROENTERITIS

EOSINOPHILIC GASTROENTERITIS

EOSINOPHILIC GASTROENTERITIS



EOSINOPHILIC GASTROENTERITIS

Eosinophilic gastroenteritis is a rare primary eosinophilic gastrointestinal disorder of unknown cause characterized by the presence of an intense eosinophilic infiltrate in one or more gastrointestinal layers.

CRONKHITE-CANADA SYNDROME AND OTHER RARE DIARRHEAL DISORDERS

CRONKHITE-CANADA SYNDROME AND OTHER RARE DIARRHEAL DISORDERS

CRONKHITE-CANADA SYNDROME AND OTHER RARE DIARRHEAL DISORDERS


Cronkhite-Canada Syndrome and Other Rare Diarrheal Disorders




Cronkhite-Canada Syndrome

Cronkhite-Canada syndrome is a rare, nonfamilial gastrointestinal polyposis syndrome that commonly presents with diarrhea. It is characterized by hyperpig-mentation, hair loss, and dystrophic changes in the fingernails. Individuals of European and Asian descent are most frequently affected, but the syndrome has been reported in all ethnic groups. The cause is not known, but the frequent association with hypothyroidism, systemic lupus erythematosus, rheumatoid arthritis, and scleroderma suggests an autoimmune origin. The syndrome is characterized by development of innumerable polyps throughout the gastrointestinal tract except in the esophagus. The polyps are hamartomas; there is an increased risk of colorectal cancer (25%), however. Patients commonly present with diarrhea and weight loss accompanied by typical dermatologic manifestations that include hyperpigmentation and onychodystrophy. Management is largely supportive, with nutritional support, accompanied by antisecretory and antiinflammatory treatment. Immunosuppressive therapy with glucocorticosteroids and azathioprine has also been reported to ameliorate symptoms, but the duration of treatment is not known.

CROHN DISEASE

CROHN DISEASE

CROHN DISEASE


IMAGING AND REGIONAL VARIATIONS
IMAGING AND REGIONAL VARIATIONS


In the United States, approximately 1.5 million individuals have Crohn disease. Crohn disease is one disease in a larger group of inflammatory bowel disorders, which includes ulcerative colitis, indeterminate colitis, and microscopic colitis. Crohn disease is a progressive illness characterized by transmural inflammation within the digestive tract that may occur anywhere from mouth to anus. Skip lesions of normal and inflamed, “cobblestoned” mucosa describe its classic luminal appearance. The phenotype is characterized by the disease’s severity, site, and type of manifestation, whether inflammatory, fibrostenotic, or fistulizing.

Sunday, October 5, 2025

TYPHOID FEVER

TYPHOID FEVER

TYPHOID FEVER

TYPHOID FEVER: TRANSMISSION AND PATHOLOGIC LESIONS
TYPHOID FEVER: TRANSMISSION AND PATHOLOGIC LESIONS


In popular culture, the potential devastation of typhoid fever has been best illustrated by the story of Typhoid Mary, also known as Mary Mallon, the personal chef to numerous affluent families in the greater New York City area in the early 20th century. She was an asymptomatic chronic carrier of the Salmonella enterica serotype typhi (previously, S. typhi) and caused approximately 50 deaths as she moved between families, rejecting the notion that she had a role in their demise. She spent the bulk of her last 30 years of life in and out of quarantine.

INFECTIOUS ENTERITIS

INFECTIOUS ENTERITIS

INFECTIOUS ENTERITIS

VIRAL ENTERITIS
VIRAL ENTERITIS


Infectious enteritis is a common worldwide illness with a multitude of underlying pathogens at play. The majority of infectious diarrheal diseases are acute in onset duration (< 2 weeks). Globally, acute enteritis is the fifth leading cause of death across all ages. Innumerable studies demonstrate that approximately 70% to 75% of acute diarrhea cases are viral in cause. Previously, culture techniques could not isolate most bacteria. With the advent of deep 16S ribosomal polymerase chain reaction sequencing techniques, genetic signatures can now identify bacteria, so it is not necessary to rely on tedious culture techniques. These technologies have isolated a bacterial source in approximately 15% of acute enteritis cases. Protozoal organisms are responsible for a lesser fraction of these cases.

HIV/AIDS Enteropathy

HIV/AIDS Enteropathy

HIV/AIDS Enteropathy

HIV/AIDS Enteropathy


Up to 50% of HIV patients in the United States report diarrhea, but a distinct cause is identified in only 60% to 70% of these cases. HIV enteropathy is characterized by chronic diarrhea lasting more than 4 weeks and accompanied by malabsorption and abdominal discomfort. As is characteristic of small bowel diarrhea, stools are typically voluminous and may occur postprandially. There may be marked electrolyte disturbances, severe dehydration, and unintentional weight loss.

Sunday, September 28, 2025

POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER


Solid-organ and allogeneic hematopoietic cell transplantation have revolutionized our ability to treat disease. Immunosuppression may have negative consequences, however, such as an earlier onset and an increased frequency of malignant tumors of the skin, cervix, and colon. A new entity, a group of disorders collectively known as post-transplant lymphoproliferative disorders (PTLDs), has emerged. The group contains primarily of B-cell–mediated lymphoid and/or plasmacytic cell proliferations that have the potential for malignant transformation to lymphoma. They are the most common causes of malignancy, following solid- organ transplantation. Conversely, PTLDs account for only a minority of cancers following hematopoietic cell transplantation. The risk is highest in the first year and then drops significantly. PTLDs remain a significant cause of early graft failure and death, however.

ABDOMINAL AND INTESTINAL TUBERCULOSIS

ABDOMINAL AND INTESTINAL TUBERCULOSIS

ABDOMINAL AND INTESTINAL TUBERCULOSIS

APPEARANCE OF MUCOSA
APPEARANCE OF MUCOSA


Worldwide, tuberculosis presents with an incidence of 7 to 10 million new cases per year, with a prevalence of approximately 2 billion people. Tuberculosis accounts for 6% of global deaths. Intestinal tuberculosis is the sixth most prevalent extrapulmonary manifestation (EPTB); it mimics primary disease of the entire digestive tract presenting as Crohn ileocolitis. Tuberculosis can also manifest as a disease affecting the peritoneum, presenting as peritonitis. Multiple factors additively contribute to propagating tuberculosis, including poverty, malnutrition, overcrowding, immigrant status, and the presence of HIV coinfection. Patients with HIV coinfection demonstrate a deficient cellular immune response, poor immune reconstitution, and a risk for latent tuberculosis reactivation. Hence, a higher incidence of EPTB, increased severity of disease, and more rapid progression of disease may be observed.

MYCOBACTERIUM AVIUM INTRACELLULARE INFECTION

MYCOBACTERIUM AVIUM INTRACELLULARE INFECTION

MYCOBACTERIUM AVIUM INTRACELLULARE INFECTION

MYCOBACTERIUM AVIUM INTRACELLULARE INFECTION


Historically, Mycobacterium tuberculosis infection was common throughout the world, particularly in underprivileged societies. Fortunately, the advent of antitubercular regimens dramatically eradicated the illness. A distinct cohort of nontuberculous mycobacterial pathogens was revealed to exist, however. Nontuberculous mycobacterial illness is predominantly caused by Mycobacterium avium-intracellulare (MAC) and Mycobacterium kansasii, with over 140 distinct species identified. Interestingly, before antiretroviral therapy was available for AIDS, MAC infection was more common in developed nations than underprivileged nations; this fact prompted the hypothesis that bacillus Calmette-Guérin vaccination or a history of tuberculosis may confer immunity. Intradermal reactivity rates were demonstrated to be equal in MAC patients in both developed and underdeveloped nations, however. The pathogenesis of the disease is poorly understood, but several mechanisms have been revealed.

Wednesday, September 24, 2025

SMALL BOWEL MANIFESTATIONS OF SYSTEMIC DISEASES

SMALL BOWEL MANIFESTATIONS OF SYSTEMIC DISEASES

SMALL BOWEL MANIFESTATIONS OF SYSTEMIC DISEASES

CONNECTIVE TISSUE DISORDER AND DERMATOLOGIC DISEASES
CONNECTIVE TISSUE DISORDER AND DERMATOLOGIC DISEASES


Connective Tissue Disorders

Scleroderma frequently involves the small bowel, primarily causing dysmotility. It is characterized by a dilated bowel, associated with scattered wide-mouthed diverticula and even intestinal pseudoobstruction, and small intestinal bacterial overgrowth.

INTESTINAL OBSTRUCTION

INTESTINAL OBSTRUCTION

INTESTINAL OBSTRUCTION

OBSTRUCTION AND ADYNAMIC ILEUS OF SMALL INTESTINE
OBSTRUCTION AND ADYNAMIC ILEUS OF SMALL INTESTINE


Small intestinal obstruction occurs when the normal propulsion of luminal contents is hindered by either mechanical obstruction or abnormal intestinal motility. The obstruction may be partial or complete and can occur at any level of the small bowel.

Sunday, May 18, 2025

Lymphatic Drainage of Mouth and Pharynx

Lymphatic Drainage of Mouth and Pharynx


Lymphatic Drainage of Mouth and Pharynx

Lymphatic Drainage of Mouth and Pharynx, jugulodigastric node

Lymphatic fluid, carried by the lymphatic capillaries in the tissues of the mouth and pharynx, is all eventually taken by the lymphatic vessels, either directly or with the interruption by interposed lymph nodes, to the chain of lymph nodes lying along the internal jugular vein. The efferent vessels from these nodes enter into the formation of the jugular lymphatic trunk, which, characteristically, on the left side empties into the thoracic duct near its termination and on the right side into the right lymphatic duct. The thoracic duct and the right lymphatic duct pour their lymph into the bloodstream at the junction of the internal jugular and subclavian veins on the respective side. On either side the jugular trunk may empty directly into the veins near this site.

Monday, April 28, 2025

Gastrointestinal Hormones

Gastrointestinal Hormones

Gastrointestinal Hormones

Gastrointestinal Hormones

The epithelium of the gastrointestinal tract contains multiple cell types, including specialized cells termed enteroendocrine cells that number less than 1% of the cell population and yet form the largest endocrine system of the body. Enteroendocrine cells synthesize, store, and release chemical transmitters that are involved in gastrointestinal motility, secretion, and absorption and in regulation of appetite. These transmitters are predominantly small polypeptides that are also found in the enteric nervous system and the central nervous system. There are more than 30 gut peptide hormone genes identified, which express more than 100 bioactive peptides. They are grouped into “families” according to their primary structure. In this section, the pancreatic polypeptide family will be discussed.

Saturday, April 26, 2025

Development of Esophagus

Development of Esophagus


Development of Esophagus

Development of Esophagus


The esophagus is the first section of the foregut and begins at the distal end of the pharynx. As with the rest of the digestive tract, the cells that line the lumen of the esophagus are derived from endoderm. The sup­ porting structures of the esophagus come from two different sources, although they are all innervated by the vagus nerve. The muscles and connective tissues of the esophagus’s proximal third are derived from the mesenchyme of the pharyngeal arches. Like the pharynx, the skeletal muscle of the superior esophagus is innervated by axons from the nucleus ambiguus traveling in the vagus nerve. The muscles and connective tissues of the distal third of the esophagus are derived from the visceral mesoderm that surrounds the gut tube. For this reason, the muscular layers of this area are composed of smooth muscle, innervated largely by the dorsal vagal motor nucleus, also traveling in the vagus nerve. The middle third of the esophagus blends the characteristics of the other two, containing both skeletal and smooth muscle.
Secretory, Digestive, and Absorptive Functions of Small and Large Intestines

Secretory, Digestive, and Absorptive Functions of Small and Large Intestines

Secretory, Digestive, and Absorptive Functions of Small and Large Intestines

DIGESTION OF PROTEIN
DIGESTION OF PROTEIN


The purpose of the complex enzymatic reactions to which foodstuffs are exposed within the intestinal lumen is to prepare nutrients for transfer into and assimilation within the organism. The lumen of the digestive system, which is the space encompassed by the wall of the digestive tube, belongs, fundamentally speaking, to the outside world, and the processes by which the products of digestion enter and pass through the intestinal wall into the circulation are called secretion and absorption, respectively. The mucosa of the small intestine throughout its length is lined by cells involved with both secretion and absorption: mucus-secreting cells, neuroendocrine cells, and immune active cells. The incredible efficiency of intestinal function is emphasized by the fact that of the approximately 8 L of fluid that enters the small intestine, only 100 to 200 mL is excreted from the rectum, for an efficiency rate in excess of 98%. In disease states, the large and small intestines absorb even more fluid, sometimes exceeding 25 L per day. Alternatively, in secretory disorders and infection, the volume of diarrhea lost may rapidly pose a life-threatening risk of dehydration, with the loss of many liters of fluids and their accompanying electrolytes.

Anatomy Physiology

[AnatomyPhysiology][recentbylabel2]

Featured

[Featured][recentbylabel2]
Notification
This is just an example, you can fill it later with your own note.
Done